Recreational marathon running does not cause exercise-induced left ventricular hypertrabeculation.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 18 03 2020
revised: 19 04 2020
accepted: 27 04 2020
pubmed: 4 5 2020
medline: 15 5 2021
entrez: 4 5 2020
Statut: ppublish

Résumé

Marathon running in novices represents a natural experiment of short-term cardiovascular remodeling in response to running training. We examine whether this stimulus can produce exercise-induced left ventricular (LV) trabeculation. Sixty-eight novice marathon runners aged 29.5 ± 3.2 years had indices of LV trabeculation measured by echocardiography and cardiac magnetic resonance imaging 6 months before and 2 weeks after the 2016 London Marathon race, in a prospective longitudinal study. After 17 weeks unsupervised marathon training, indices of LV trabeculation were essentially unchanged. Despite satisfactory inter-observer agreement in most methods of trabeculation measurement, criteria defining abnormally hypertrabeculated cases were discordant with each other. LV hypertrabeculation was a frequent finding in young, healthy individuals with no subject demonstrating clear evidence of a cardiomyopathy. Training for a first marathon does not induce LV trabeculation. It remains unclear whether prolonged, high-dose exercise can create de novo trabeculation or expose concealed trabeculation. Applying cut off values from published LV noncompaction cardiomyopathy criteria to young, healthy individuals risks over-diagnosis.

Sections du résumé

BACKGROUND
Marathon running in novices represents a natural experiment of short-term cardiovascular remodeling in response to running training. We examine whether this stimulus can produce exercise-induced left ventricular (LV) trabeculation.
METHODS
Sixty-eight novice marathon runners aged 29.5 ± 3.2 years had indices of LV trabeculation measured by echocardiography and cardiac magnetic resonance imaging 6 months before and 2 weeks after the 2016 London Marathon race, in a prospective longitudinal study.
RESULTS
After 17 weeks unsupervised marathon training, indices of LV trabeculation were essentially unchanged. Despite satisfactory inter-observer agreement in most methods of trabeculation measurement, criteria defining abnormally hypertrabeculated cases were discordant with each other. LV hypertrabeculation was a frequent finding in young, healthy individuals with no subject demonstrating clear evidence of a cardiomyopathy.
CONCLUSION
Training for a first marathon does not induce LV trabeculation. It remains unclear whether prolonged, high-dose exercise can create de novo trabeculation or expose concealed trabeculation. Applying cut off values from published LV noncompaction cardiomyopathy criteria to young, healthy individuals risks over-diagnosis.

Identifiants

pubmed: 32360651
pii: S0167-5273(20)31104-9
doi: 10.1016/j.ijcard.2020.04.081
pmc: PMC7438970
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-71

Subventions

Organisme : British Heart Foundation
ID : FS/15/27/31465
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/16/46/32187
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/20/2/34841
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The study funders and supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Références

J Cardiovasc Magn Reson. 2018 Oct 25;20(1):70
pubmed: 30355287
Int J Cardiol. 2014 Oct 20;176(3):1134-6
pubmed: 25156849
Heart. 2019 Jul;105(13):990-998
pubmed: 30723101
Circulation. 1990 Aug;82(2):507-13
pubmed: 2372897
Int J Cardiol. 2016 Nov 15;223:590-595
pubmed: 27561165
J Magn Reson Imaging. 2016 Jun;43(6):1398-406
pubmed: 26646347
Heart. 2001 Dec;86(6):666-71
pubmed: 11711464
Front Physiol. 2020 Mar 18;11:232
pubmed: 32256389
Heart. 2013 Mar;99(6):401-8
pubmed: 23393084
J Am Coll Cardiol. 2005 Jul 5;46(1):101-5
pubmed: 15992642
Diagn Interv Imaging. 2018 Nov;99(11):689-698
pubmed: 30262171
Circ Cardiovasc Imaging. 2020 Jan;13(1):e009712
pubmed: 31959004
JACC Cardiovasc Imaging. 2015 Nov;8(11):1252-7
pubmed: 26563854
J Cardiovasc Magn Reson. 2013 May 10;15:36
pubmed: 23663522
Circ Cardiovasc Imaging. 2011 Mar;4(2):139-46
pubmed: 21193690
Int J Cardiol. 2015 Feb 15;181:320-2
pubmed: 25544199
Circulation. 2014 Aug 5;130(6):475-83
pubmed: 25006201
Eur Heart J. 2010 May;31(9):1098-104
pubmed: 20089517

Auteurs

Andrew D'Silva (A)

Cardiology Clinical & Academic Group, St George's University of London, London, UK. Electronic address: adsilva@nhs.net.

Gabriella Captur (G)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Anish N Bhuva (AN)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Siana Jones (S)

Institute for Cardiovascular Science, University College London, London, UK.

Rachel Bastiaenen (R)

Guy's and St Thomas' NHS Foundation Trust, London, UK.

Amna Abdel-Gadir (A)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Sabiha Gati (S)

East and North Hertfordshire NHS Trust, Stevenage, UK.

Jet van Zalen (J)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.

James Willis (J)

Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.

Aneil Malhotra (A)

Cardiology Clinical & Academic Group, St George's University of London, London, UK.

Irina Chis Ster (IC)

Infection and Immunity Research Institute, St George's, University of London, London, UK.

Charlotte Manisty (C)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Alun D Hughes (AD)

Institute for Cardiovascular Science, University College London, London, UK.

Guy Lloyd (G)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Rajan Sharma (R)

Cardiology Clinical & Academic Group, St George's University of London, London, UK.

James C Moon (JC)

Institute for Cardiovascular Science, University College London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Sanjay Sharma (S)

Cardiology Clinical & Academic Group, St George's University of London, London, UK. Electronic address: sasharma@sgul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH